Stock A006280 GC BIOPHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases GC Biopharma Corp.

Equities

A006280

KR7006280002

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/05/2024 BST 		5-day change 1st Jan Change
113,500 KRW -1.90% Intraday chart for GC Biopharma Corp. +2.16% -9.56%
06:37am Green Cross Widens Q1 Loss, Sales Inch Up 2% MT
03-20 GC Biopharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent
PU
Green Cross : Curevo Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
PU
Green Cross : GC Pharma Reports Q1 2020 Results
AQ
Green Cross : GC Pharma Reports Full Year 2019 Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A006280 Stock
  4. News GC Biopharma Corp.
  5. Press Releases